Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulin

The Journal of Pediatrics

Volumn 117, Issue 4, 1990, Pages 638-644

  Barron, Karyl S ^{a,b,c,d,e,f,g,h,i,j}   Murphy Jr , Daniel J ^{a,b,c,d,e,f,g,h,i,j}   Silverman, Earl D ^{a,b,c,d,e,f,g,h,i,j}   Ruttenberg, Herbert D ^{a,b,c,d,e,f,g,h,i,j}   Wright, Gregory B ^{a,b,c,d,e,f,g,h,i,j}   Franklin, Wayne ^{a,b,c,d,e,f,g,h,i,j}   Goldberg, Stanley J ^{a,b,c,d,e,f,g,h,i,j}   Higashino, Stanley M ^{a,b,c,d,e,f,g,h,i,j}   Cox, Dianne G ^{a,b,c,d,e,f,g,h,i,j}   Lee, Martin ^{a,b,c,d,e,f,g,h,i,j}  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF ARIZONA   (United States)

ⁱ CHILDREN S HOSPITAL OAKLAND   (United States)

^j BAXTER HEALTHCARE CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN G;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY ANEURYSM; DRUG DOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL;

ASPIRIN; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; CORONARY ANEURYSM; ECHOCARDIOGRAPHY; FEMALE; HUMAN; IMMUNOGLOBULIN G; INFANT; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0025084527     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(05)80707-3     Document Type: Article

References (20)

1. High-dose intravenous gammaglobulin for Kawasaki disease
2. High-dose intravenous gammaglobulin for Kawasaki disease
3. High-dose gammaglobulin therapy for Kawasaki disease
4. The treatment of Kawasaki syndrome with intravenous gamma globulin
5. Prevention of coronary artery involvement in Kawasaki disease by early intravenous high-dose gamma globulin
6. Intravenous gamma globulin therapy in Kawasaki disease: trial of low-dose gamma globulin
7. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease
8. Efficacy of a new intravenous immunoglobulin in primary immunodeficient patients
9. Abnormalities of immunoregulation in Kawasaki syndrome
10. Treatment of Kawasaki syndrome
11. Rickettsia-like bodies and splenitis in Kawasaki disease
12. Kawasaki disease: its pathological features and possible pathogenesis
13. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease
14. Does Kawasaki disease have a retroviral etiology?
15. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome
16. Characterization of the polymerase activity associated with cultured peripheral blood mononuclear cells from patients with Kawasaki disease
17. Japanese gamma globulin trials for Kawasaki disease
18. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease
19. Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms
20. Intravenous gamma-globulin use in children with Kawasaki disease